MAX in cancer: dynamic role of MYC’s partner-in-crime

Trends in Cancer · Published 2026-03-01 · DOI 10.1016/j.trecan.2026.01.001

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.trecan.2026.01.001

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• MYC in Oncogenesis and Therapeutic Implications · MedComm · 2026 · Cites or is cited by this article
• A novel mechanism of autophagy-dependent immunosuppression in cancer? · Trends in Cancer · 2026 · Same journal
• LGR5: from stem cell marker to therapeutic target · Trends in Cancer · 2026 · Same journal
• Cancer in 4D: toward Spatiotemporal Hallmark Ecosystems · Trends in Cancer · 2026 · Same journal
• Mitochondrial transfer reveals an organellar layer of cancer ecology · Trends in Cancer · 2026 · Same journal
• Circulating tumor DNA in biliary tract cancers: challenges, opportunities, and clinical readiness · Trends in Cancer · 2026 · Same journal
• Neural checkpoint therapy in lung cancer · Trends in Cancer · 2026 · Same journal
• Bioengineered systems to exploit tumor microenvironment metabolism · Trends in Cancer · 2026 · Same journal
• Advisory Board and Contents · Trends in Cancer · 2026 · Same journal
• Horizontal mitochondrial transfer and the tug-of-war between cancer cells and immune cells · Trends in Cancer · 2026 · Same journal